VC firm
The Global BioAccess Fund
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- New York, United States
- Check size
- We can invest up to $10M throughout the lifespan of a company. However, with our limited partners (LPs) we can invest additional funds in later stage rounds.Source (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in Oncology, I&I, cardiovascular, CNS, and rare diseases.
Investment approach
- Thesis
- The Global BioAccess Fund invests in companies developing novel therapeutics and devices to address serious unmet medical needs in Oncology, I&I, rare disease, CNS and cardiology. We fund early-stage companies who need capital to support IND submission and clinical trials.Source (opens in a new tab)
- Investing status notes
- We invest in transformative technologies that address unmet needs in Oncology, I&I, cardiovascular, CNS, and rare diseases.
Locations
- Headquarters
- New York, United States
Loading relationship preview